Jan. 15, 2025 — Researchers have designed process that uses ultrasound to modify the behavior of cancer-fighting T cells by increasing their cell permeability. They targeted freshly isolated ...

Sanofi is still plugging away with its oral BTK inhibitor tolebrutinib in multiple sclerosis, but has decided to abandon efforts to develop the drug for neuromuscular disorder myasthenia gravis.

Despite the history of myasthenia gravis, the prior thymectomy made a thymoma unlikely. Lymphoma and sarcoidosis were also in the differential, but the absence of classic radiological features such as ...

Mission Statement: Evidence-based Complementary and Alternative Medicine (eCAM) is an international, peer-reviewed journal that seeks to understand the sources and to encourage rigorous research ...

Graviss Hospitality Ltd., incorporated in the year 1959, is a Small Cap company (having a market cap of Rs 349.85 Crore) operating in Tourism & Hospitality sector. Graviss Hospitality Ltd. key ...